EN DE
STOCK COMPARISON

Exa E&c vs Fischer Medical Ventures: Fair Value & Quality

Both stocks run through our valuation models. Here is how Exa E&c (054940) and Fischer Medical Ventures (FISCHER) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees Exa E&c as the less overvalued of the two: Exa E&c trades at KRW 738 versus a fair value of KRW 444 (-40%), while Fischer Medical Ventures trades at ₹38.90 versus ₹6.85 (-82%).
Exa E&c
054940.KQ · KRW · Industrials
-40%
upside to fair value
overvalued
PriceKRW 738
Fair ValueKRW 444
Quality49/100
Fischer Medical Ventures
FISCHER.BSE · INR · Industrials
-82%
upside to fair value
overvalued
Price₹38.90
Fair Value₹6.85
Quality40/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Exa E&cFischer Medical Ventures
Valuation
—P/E (TTM)87.4×
—P/S (TTM)8.34×
—P/B6.69×
—EV/EBITDA62.8×
—Dividend yield0.1%
—Dividend per share₹0.05
Profitability
7%Net margin10%
7%Operating margin0%
—Return on equity9%
7%Return on assets4%
Growth
10%Revenue growth (YoY)99%
-7.9%Avg. growth/yr (3Y)1,097.9%
-5.5%Avg. growth/yr (5Y)351.2%
Balance & size
0.14×Debt / equity0.00×
$18MMarket cap$270M
weakGrowth qualitymixed

Fischer Medical Ventures leads: 2 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Exa E&cof which business quality 47 · market factors 39 Fischer Medical Venturesof which business quality 41 · market factors 28
ProfitabilityMargins and returns on capital today
33
37
Quality GrowthAre margins and returns improving?
15
89
CashflowEarnings quality: real cash, not paper profit
36
0
Fin. StrengthBalance sheet, leverage, solvency risk
49
77
InvestmentDisciplined investing over empire-building
87
50
Low VolatilityCalm price path (market factor)
40
54
MomentumPrice trend over the last 3–12 months (market factor)
40
24
52W MomentumDistance to the 52-week high (market factor)
36
4
Net IssuanceBuybacks instead of dilution
82
0

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Exa E&c

DCF ModelsKRW 1,000
Earnings-BasedKRW 527
MultiplesKRW 921
Asset-BasedKRW 1,392
Growth DCFKRW 711
Economic ProfitKRW 1,094
Growth EarningsKRW 303

7 of 20 models see the stock below the current price.

Fischer Medical Ventures

DCF Models₹18.02
Earnings-Based₹16.59
Dividend Discount₹0.08
Multiples₹8.44
Asset-Based₹3.93
Economic Profit₹6.12
Growth Earnings₹21.70

17 of 17 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Exa E&c
Bear KRW 300Fair Value KRW 444Bull KRW 555
KRW 738 = current price (white tick)
Fischer Medical Ventures
Bear ₹4.62Fair Value ₹6.85Bull ₹8.56
₹38.90 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Exa E&c · Industrials

Quality score49 · below median
Fair value upside-40% · below median

Fischer Medical Ventures · Industrials

Quality score40 · bottom 25%
Fair value upside-82% · bottom 25%

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees Exa E&c as the less overvalued of the two: Exa E&c trades at KRW 738 versus a fair value of KRW 444 (-40%), while Fischer Medical Ventures trades at ₹38.90 versus ₹6.85 (-82%).

Exa E&c has the higher quality score (49/100).

See the full analysis →
Exa E&c · Fischer Medical Ventures

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Exa E&c

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Toyota Motor Corporation

Related to Fischer Medical Ventures

Amazon.com vs PDD HoldingsAmazon.com vs Sony GroupMeta Platforms vs Verizon CommunicationsMeta Platforms vs At&t
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.